FierceBiotech

Arcturus says sa-mRNA COVID boosters induced immune response in small phase 1/2 study

A dwindling COVID-19 vaccine market is not stopping Arcturus Therapeutics from pressing ahead with its own mRNA candidate, as the biotech touts new early data indicating its shot lights up the immune ...
The Business Journals

Downtown SA hotels remain in Covid recovery

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Visit San Antonio's CEO is ...
The Business Journals

After enduring Covid crash, SA firm seeing new surge in hotel business

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Markets like Austin and Houston ...
Business Wire

Study Shows Novel sa-mRNA Vaccines Offer Robust, Broad, Enduring Protection Against COVID-19 Variants

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of ...
Nasdaq

New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster

KING OF PRUSSIA, Pa. & SAN DIEGO--(BUSINESS WIRE)-- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the results of a follow-up analysis ...